Global Troponin Complex Market Size, Share and Trends Analysis Report, By Application (Myocardial Infarction, Acute Coronary Syndrome, Other), Forecast (2022-2028)

The global troponin complex market is anticipated to grow at a significant CAGR of 7.3% during the forecast period (2022-2028). Troponin complex is a component of skeletal and cardiac muscle thin filaments. It consists of three subunits – troponin I, T, and C, and it plays a crucial role in muscle activity, connecting changes in intracellular Ca2+ concentration with the generation of contraction. The global troponin complex market is growing due to the rising prevalence of cardiovascular disorders globally. According to World Health Organization 2021, cardiovascular disease is considered the leading cause of death globally. An estimated 17.9 million people died from cardiovascular diseases in 2019, representing 32% of the total global deaths. Among them, 85% of deaths were due to heart attack and stroke.

The increasing prevalence of acute coronary syndrome along with advancements in the cardiac biomarkers is further boosting the growth of the global troponin complex market. The increasing demand for point-of-care cardiac testing kits globally is also anticipated to propel the growth of the market.

The North American region holds the major share in the global troponin complex market. This is due to their early adoption of new treatment methods as well as their advanced healthcare infrastructure. The presence of major market players and their investment in research and development is also boosting the growth of the North American troponin complex market.

Some of the major players in the market include Siemens Healthcare GmbH, Abbott, F. Hoffmann-La Roche Ltd., Mitsubishi Tanabe Pharma Corp., and BIOMÉRIEUX among others. These market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new drug launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Siemens Healthcare GmbH, Abbott, F. Hoffmann-La Roche Ltd., Mitsubishi Tanabe Pharma Corp., and BIOMÉRIEUX, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Artesunate Used for Malaria Market Report by Segment

By Application

• Myocardial Infarction
• Acute Coronary Syndrome
• Other

Global Artesunate Used for Malaria Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa